Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
     

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Index Total Return Ticker

      MVBBHTR
    • Index Provider

      Market Vectors Index Solutions
    • Total Net Assets

      $490.8M
    • Shares Outstanding

      5,746,503
    • Number of Holdings

      26
    • Commencement Date

      12/20/2011
  •  
    as of 04/17/14

  • Portfolio Composition (%)
    as of 04/17/14

    • % of Net Assets

    • Stocks

      99.99
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.01
    • Total

      100.00
  • Download All Holdings All Holdings (%) as of 04/17/14

    Total Holdings: 26
    Holding Name
    Ticker
    Shares Market Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    884,926
    61,944,820 12.62
    Amgen Inc
    AMGN US
    485,942
    56,106,863 11.43
    Biogen Idec Inc
    BIIB US
    152,151
    44,205,952 9.01
    Celgene Corp
    CELG US
    306,383
    43,356,258 8.83
    Regeneron Pharmaceuticals Inc
    REGN US
    85,359
    25,329,430 5.16
    Alkermes Plc
    ALKS US
    558,156
    24,625,843 5.02
    Alexion Pharmaceuticals Inc
    ALXN US
    162,624
    24,361,075 4.96
    Vertex Pharmaceuticals Inc
    VRTX US
    326,530
    20,953,430 4.27
    Illumina Inc
    ILMN US
    153,966
    20,854,695 4.25
    Biomarin Pharmaceutical Inc
    BMRN US
    314,918
    19,175,357 3.91
    Qiagen Nv
    QGEN US
    854,976
    17,569,757 3.58
    Incyte Corp Ltd
    INCY US
    364,390
    16,229,931 3.31
    Isis Pharmaceuticals Inc
    ISIS US
    454,888
    15,470,741 3.15
    Pharmacyclics Inc
    PCYC US
    139,257
    12,498,316 2.55
    Covance Inc
    CVD US
    127,424
    12,356,305 2.52
    United Therapeutics Corp
    UTHR US
    124,857
    12,011,243 2.45
    Medivation Inc
    MDVN US
    200,744
    11,629,100 2.37
    Cubist Pharmaceuticals Inc
    CBST US
    176,258
    11,271,699 2.30
    Charles River Laboratories Internationa
    CRL US
    140,194
    8,003,675 1.63
    Cepheid Inc
    CPHD US
    136,501
    6,542,493 1.33
    Intercept Pharmaceuticals Inc
    ICPT US
    26,419
    6,343,202 1.29
    Myriad Genetics Inc
    MYGN US
    151,958
    5,769,845 1.18
    Nps Pharmaceuticals Inc
    NPSP US
    212,705
    5,221,908 1.06
    Seattle Genetics Inc
    SGEN US
    118,976
    4,621,028 0.94
    Ariad Pharmaceuticals Inc
    ARIA US
    606,337
    4,365,626 0.89
    Other/Cash
    28,521 0.01
    Total (%) 100.02
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.